| [1] |
CAO Can, XIE Kun, ZENG Weili.
The mechanism of miR-451 on regulating differentiation of 3T3-L1 preadipocytes through AMPK signaling pathway
[J]. Tianjin Medical Journal, 2026, 54(8): 785-789.
|
| [2] |
YANG Liheng, LI Yi, LIU Shuang, KONG Nan, ZHANG Dongrui, JIA Wei.
Multidisciplinary diagnosis and treatment analysis of pulmonary tuberculosis latent infection activation in a lung cancer patient after immune checkpoint inhibitor therapy
[J]. Tianjin Medical Journal, 2026, 54(8): 874-880.
|
| [3] |
HU Jinbao, LIU Wenwu, HU Zhichao.
The correlation between serum microRNA and degree of macular edema in patients with retinal vein occlusion
[J]. Tianjin Medical Journal, 2026, 54(7): 741-746.
|
| [4] |
ZHANG Jing, ZHANG Ming, WEI Wei, NING Haihong, WEI Hongmei, LI Haiyan, WU Bin.
Protective effect and mechanism of miR-194-5p inhibitor on myocardial injury in mice with type 2 diabetic cardiomyopathy
[J]. Tianjin Medical Journal, 2026, 54(6): 577-584.
|
| [5] |
LU Hongxia, GUO Yanjun, HUANG Han, ZHANG Ting.
MiR-421 targeting the MPP7/EGFR/AKT axis to regulate macrophage M2 polarization and alleviating airway inflammation in asthmatic mice
[J]. Tianjin Medical Journal, 2026, 54(5): 462-468.
|
| [6] |
CHEN Sumei, ZHOU Quan.
Distribution of pathogenic bacteria in incisional infections of closed lower limb fracture and expression analysis of miR-15b-5p/IKBKB signaling pathway-related molecules
[J]. Tianjin Medical Journal, 2026, 54(4): 379-383.
|
| [7] |
YANG Xiaofang, JIA Xinyan, FENG Wenjun.
MiR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells in lupus nephritis mice through HMGB1/NF-κB signaling pathway
[J]. Tianjin Medical Journal, 2026, 54(3): 232-237.
|
| [8] |
HUANG Huiqi, WU Qiuyuan, ZHANG Kun, LI Peixian, XIONG Yaming, YE Guolin, ZHOU Dan.
Research on the anti-tumor mechanism of toosendanin combined with olaparib in triple negative breast cancer
[J]. Tianjin Medical Journal, 2025, 53(9): 897-902.
|
| [9] |
SONG Shanshan, JIANG Min, WANG Liang, HUANG Bozhen, WANG Guoyu, LIU Xinxin, MA Siyi.
The global burden of tracheal, bronchial and lung cancer disease from 1990 to 2021 and the forecast to 2040
[J]. Tianjin Medical Journal, 2025, 53(8): 875-883.
|
| [10] |
WANG Haicheng, ZHAO Yihan, XIE Meiyi, ZHAO Yuming.
Predictive value of SUVmax and SUVmean parameters in 18F-PSMA-1007 PET/CT for the diagnosis and disease progression of prostate cancer
[J]. Tianjin Medical Journal, 2025, 53(6): 614-618.
|
| [11] |
ZHOU Meijuan, MIAO Xiaoxiang.
Relationship between serum expression levels of miR-214-3p and miR-124-3p and the severity of disease in patients with Parkinson's disease and their values in early diagnosis
[J]. Tianjin Medical Journal, 2025, 53(5): 498-502.
|
| [12] |
QI Weihua, HUANG Guanglei, ZHANG Yuanyuan, BAN Hongying, MAO Zhaoxu.
Effect of forsythigenin on the malignant progression of lung cancer cells by regulating the cAMP/EPAC1/RAP1 signal pathway
[J]. Tianjin Medical Journal, 2025, 53(4): 343-348.
|
| [13] |
WANG Chao, ZHANG Junmei, ZHANG Peng, LIU Li, WANG Xiaochun.
Comparison of efficacy of recombinant human interleukin-11 and herombopag olamine tablets on chemotherapy-induced thrombocytopenia in breast cancer
[J]. Tianjin Medical Journal, 2025, 53(4): 365-369.
|
| [14] |
LI Na, HE Ying, TENG Fei, HE Wenshu, GUO Caifeng, ZHONG Na, WU Qiong, LI Jun.
The application value of ultrasound BI-RADS classification combined with serum FGFR1 and GDF3 in the differential diagnosis of benign and malignant breast masses
[J]. Tianjin Medical Journal, 2025, 53(3): 247-251.
|
| [15] |
WANG Wei, XIA Haishui, MA Shang.
Efficacy of trastuzumab combined with neratinib in the treatment of HER-2 positive metastatic breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 321-325.
|